title: The Ehlers-Danlos syndrome, a disorder with many faces.
abstract: The Ehlers-Danlos syndromes (EDSs) comprise a heterogeneous group of diseases, characterized by fragility of the soft connective tissues and widespread manifestations in skin, ligaments, joints, blood vessels and internal organs. The clinical spectrum varies from mild skin and joint hyperlaxity to severe physical disability and life-threatening vascular complications. The current Villefranche classification recognizes six subtypes, most of which are linked to mutations in genes encoding fibrillar collagens or enzymes involved in post-translational modification of these proteins. Mutations in type V and type III collagen cause classic or vascular EDS respectively, while mutations involving the processing of type I collagen are involved in the kyphoscoliosis, arthrochalasis and dermatosparaxis type of EDS. Establishing the correct EDS subtype has important implications for genetic counseling and management and is supported by specific biochemical and molecular investigations. Over the last years, several new EDS variants have been characterized which call for a refinement of the Villefranche classification. Moreover, the study of these diseases has brought new insights into the molecular pathogenesis of EDS by implicating genetic defects in the biosynthesis of other extracellular matrix (ECM) molecules, such as proteoglycans and tenascin-X, or genetic defects in molecules involved in intracellular trafficking, secretion and assembly of ECM proteins.
authors.affiliation: Centre for Medical Genetics, Ghent University Hospital, Ghent University, De Pintelaan 185, Ghent, Belgium. anne.depaepe@uzgent.be
authors.forename: A
authors.initials: A
authors.lastname: De Paepe
authors.forename: F
authors.initials: F
authors.lastname: Malfait
mesh_terms: D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D003094:Collagen / Q000235:genetics; D004535:Ehlers-Danlos Syndrome / Q000145:classification / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D005109:Extracellular Matrix / Q000235:genetics*; D005817:Genetic Counseling; D018740:Genetic Heterogeneity; D006801:Humans; D007596:Joints / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D011499:Protein Processing, Post-Translational; D011509:Proteoglycans / Q000235:genetics; D012867:Skin / Q000378:metabolism / Q000473:pathology; D019063:Tenascin / Q000235:genetics
chemical_list: D011509:Proteoglycans; D019063:Tenascin; C081865:tenascin X; D003094:Collagen